Friday Letter 22/01/2021

Friday 22nd January 2021

Extension of SSP08

Due to ongoing supply issues, SSP08 for Salazopyrin® EN-Tabs 500mg has been further extended until 26th February 2021.

To view the latest SSPs and supporting guidance, please see the NHS BSA website.

If you have any questions regarding the SSP please contact the NHS Prescription Service:

Telephone: 0300 330 1349

Textphone: 18001 0300 330 1349

IPC guidance updated

The NHS Community Pharmacy Team have shared an update regarding IPC Guidance:

UPDATED: UK Infection Prevention and Control Guidance

The UK Infection Prevention and Control guidance, agreed by the UK’s four chief medical and nursing officers, has been updated to reflect the most up-to-date scientific understanding of how to prevent and control COVID-19 infection. Amendments have been made to strengthen existing messaging and provide further clarity where needed, including updates to the care pathways to recognise testing and exposure. Appendices to support the remobilisation and maintenance of dental, mental health and learning disability services have also been added.

Changes to the previous version are listed on page 7 of the guidance. Following extensive clinical and scientific review, no changes to the recommendations, including PPE, have been made in response to the new variant strains at this stage, however this position will remain under constant review. Organisations who adopt practices that differ from those recommended in the national guidance are responsible for ensuring safe systems of work, including the completion of a risk assessments approved through local governance procedures.

All NHS organisations should ensure reliable application of all IPC recommendations and assurance on adherence, that PPE is available and in supply, and that all staff training is up to date.

Valved respirator masks

Previous guidance has confirmed valved non-shrouded FFP3 respirators should be worn with a full-face shield if blood or bodily fluid splashing is anticipated. This updated guidance clarifies that valved respirators should not be worn by a healthcare worker/operator in sterile areas such as theatres/surgical settings or while undertaking a sterile procedure, such as central line insertion, as the exhaled breath is unfiltered.  In these settings, please follow the approach of fit testing staff to one or more of the seven non-valved masks currently available. New fit testing should focus on non-3M models, in line with the ongoing national resilience strategy.

For support with fit testing, please contact Anton Miedziolka in the Government’s National Fit Testing Team:

Deadline approaching: PSNC Pharmacy Advice Audit

This is a vital audit that would provide quantitative evidence to support the contract and funding negotiations carried on our behalf by PSNC with DHSC.

The deadline for the Pharmacy Advice Audit is next week, 25th January 2021.

CL Clinically Enhanced Pharmacist Independent Prescribing (CEPIP) course April 2021 cohort – APPLICATIONS NOW OPEN

UCL are currently recruiting for their Independent Prescribing Course for April 2021 start. If you wish to register, please see full details in the following flyer.

Deadline for submissions is 1st February 2021.CEPIP-flyerDownload

Dear Pharmacist,

UCL are pleased to announce that we are now recruiting for our fifth cohort of students for our fully integrated Clinically Enhanced Pharmacist Independent Prescribing course, to start in April 2021. Please see the UCL website for more information . Applications open 12th January 2021 and close on 1st February 2021.

The course has been developed by pharmacists for pharmacists. Successful completion of the course will enable you to apply for annotation of your name on the GPhC register as a prescriber.  The course incorporates five full days of physical examination skills teaching, led by medics and supported by pharmacists who use physical examination skills in their daily practice so that you can learn from their experience of extending their pharmacy role. We will be using the Clinical Skills Suite and equipment to ensure you gain hands-on experience of diagnostic skills needed for diagnosis which you can develop further with your designated medical practitioner during your supervised time in practice.

We understand that prospective students and offer-holders may have concerns about the ongoing coronavirus outbreak. The University is following the advice from current government guidelines and NHS England to ensure the safety of our students without compromising the integrity of their education.

Pharmacies registering with the eCommerce Portal

A number of pharmacies have not yet registered for the DHSC PPE eCommerce Portal. If you have not yet registered, please do so urgently to ensure you can access emergency PPE when you need it.

DHSC PPE eCommerce Portal

Please make sure you register for the DHSC PPE eCommerce Portal, even if you do not currently need to place an order. This is to ensure you have access to emergency stock if you need it.

How do you register for the PPE eCommerce Portal?

Your invitation to register with the portal has been sent from the PPE Dedicated Supply Channel team to this email account. You must use this email address to register. More information, including quantities available to order, is on the DHSC PPE portal guidance page.

If you have not received an email, please contact the PPE Dedicated Supply Channel team on 0800 876 6802. 

Common Childhood Dermatological Problems

Leo Pharmacy are holding webinar training for Common Childhood Dermatological Problems on 27th January 2021.

If you are interested, please read through the following agenda and register directly with Sarah Nawaz at shnuk@leo-pharma.come

Indemnity arrangements for the COVID-19 vaccination programme – update

Please see the following message from PSNC:

Yesterday, Nadhim Zahawi, Minister for COVID Vaccination Deployment made a statement on the provision of indemnity for the vaccination programme, including provision by community pharmacy in England.

The Minister’s statement provides clarity on why the indemnity has been provided to community pharmacy and also extends the scheme to 30th June 2021. He stated:

“Without adequate indemnity cover, pharmacies would be unable to commit to the programme… therefore, DHSC has provided a time limited clinical negligence indemnity to community pharmacy to 30 June 2021, to enable them to engage at pace with this programme … the Department and NHS England and Improvement continue to work with the community pharmacy sector on a longer-term approach to insuring community pharmacy for Covid-19 vaccinations.”

Contractors who provide COVID-19 vaccination services under Local Enhanced Service (LES) agreements are issued with a letter detailing the indemnity cover, which provides, for example, that the indemnity is provided subject to the contractor’s compliance with the terms and conditions of the LES Agreement and the terms of the indemnity arrangements.

The Minister’s statement is further to the joint letter issued by the Department of Health and Social Care and NHS England and NHS Improvement late last year.More on COVID-19 vaccinations, including indemnity arrangements

Position statement around use of the COVID-19 vaccine AstraZeneca (AZ) to vaccinate housebound patients (13 Jan 2021)

The following message was included in a recent Primary Care Bulletin from NHSE&I:

There have been queries around the movement of the AZ Vaccine once the vial has been punctured; we have worked with the National Infection Prevention and Control team to agree a way forward that reduces the risk of microbiological contamination of the unpreserved AZ vaccine and therefore the risk of infection to patients. The following statement is our recommendation.

C0943: lateral flow antigen letter for primary care

The Government has agreed that testing will be made available to all asymptomatic patient-facing NHS staff. The attached letter confirms how all four primary care contractor groups (medical, dental, optometry and community pharmacy) in England can order lateral flow testing.

Leave a Reply